Price Elizabeth, MacPhie Elizabeth, Kay Lesley, Lanyon Peter, Griffiths Bridget, Holroyd Christopher, Abhishek Abhishek, Youngstein Taryn, Bailey Kathryn, Clinch Jacqui, Shaikh Muddassir, Rivett Ali
Great Western Hospital, Swindon, UK and president, British Society for Rheumatology, London, UK.
Lancashire and South Cumbria NHS Foundation Trust, Preston, UK and chair of the Clinical Affairs Committee, British Society for Rheumatology, London, UK.
Clin Med (Lond). 2020 May 15;20(3):256-261. doi: 10.7861/clinmed.2020-0149. Print 2020 May 5.
Rheumatology teams care for patients with diverse, systemic autoimmune diseases who are often immunosuppressed and at high risk of infections. The current COVID-19 pandemic has presented particular challenges in caring for and managing this patient group. The office of the chief medical officer (CMO) for England contacted the rheumatology community to provide expert advice on the identification of extremely vulnerable patients at very high risk during the COVID-19 pandemic who should be 'shielded'. This involves the patients being asked to strictly self-isolate for at least 12 weeks with additional funded support provided for them to remain at home. A group of rheumatologists (the authors) have devised a pragmatic guide to identifying the very highest risk group using a rapidly developed scoring system which went live simultaneous with the Government announcement on shielding and was cascaded to all rheumatologists working in England.
风湿病团队负责照料患有各种全身性自身免疫性疾病的患者，这些患者通常免疫功能低下，感染风险很高。当前的新冠疫情给照料和管理这一患者群体带来了特殊挑战。英国首席医疗官办公室联系了风湿病学界，就新冠疫情期间应“屏蔽”的极高风险的极度脆弱患者的识别提供专家建议。这包括要求患者严格自我隔离至少12周，并提供额外的资金支持，让他们居家隔离。一组风湿病专家（作者）设计了一份实用指南，通过一个快速开发的评分系统来识别最高风险群体，该系统与政府关于屏蔽的公告同时启用，并传达给了在英国工作的所有风湿病专家。
